Explore more publications!
Oman Technology Reporter
Got News to Share?

Oman Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Technology Reporter.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 6, 2026

Rail Vision Advances Indian Market Entry with Demonstration for Senior Governmental Officials from Multiple Government Departments
January 6, 2026

Rail Vision Advances Indian Market Entry with Demonstration for Senior Governmental Officials from Multiple Government Departments

Indeterminate GlobeNewswire
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer
January 6, 2026

Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer

Indeterminate GlobeNewswire
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
January 6, 2026

BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer

Indeterminate GlobeNewswire
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
January 6, 2026

Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

Indeterminate GlobeNewswire
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
January 6, 2026

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

Indeterminate GlobeNewswire
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
January 6, 2026

Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies

Indeterminate GlobeNewswire
DayOne Data Centers Mengumumkan Pembiayaan Seri C Senilai Lebih dari 2 Miliar Dolar AS untuk Mempercepat Ekspansi Infrastruktur Digital Global
January 6, 2026

DayOne Data Centers Mengumumkan Pembiayaan Seri C Senilai Lebih dari 2 Miliar Dolar AS untuk Mempercepat Ekspansi Infrastruktur Digital Global

Indeterminate GlobeNewswire
DayOne Data Centers, 글로벌 디지털 인프라 확장 가속 위해 20억 달러 이상 규모 시리즈 C 투자 유치 발표
January 6, 2026

DayOne Data Centers, 글로벌 디지털 인프라 확장 가속 위해 20억 달러 이상 규모 시리즈 C 투자 유치 발표

Indeterminate GlobeNewswire
デイワン・データセンターズ、グローバルデジタルインフラの拡大を加速させるため、シリーズCで20億米ドル (約3,125億円) 超の資金調達を発表
January 6, 2026

デイワン・データセンターズ、グローバルデジタルインフラの拡大を加速させるため、シリーズCで20億米ドル (約3,125億円) 超の資金調達を発表

Indeterminate GlobeNewswire
DayOne Data Centers ประกาศการระดมทุนซีรีส์ C มูลค่ากว่า 2 พันล้านดอลลาร์สหรัฐ…
January 6, 2026

DayOne Data Centers ประกาศการระดมทุนซีรีส์ C มูลค่ากว่า 2 พันล้านดอลลาร์สหรัฐ…

Indeterminate GlobeNewswire
DayOne Data Centers Mengumumkan Pembiayaan Siri C Bernilai Lebih US$2.0 Bilion untuk Mempercepatkan Pengembangan Infrastruktur Digital Global
January 6, 2026

DayOne Data Centers Mengumumkan Pembiayaan Siri C Bernilai Lebih US$2.0 Bilion untuk Mempercepatkan Pengembangan Infrastruktur Digital Global

Indeterminate GlobeNewswire
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
January 6, 2026

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

Indeterminate GlobeNewswire
Alvotech announces planned CEO succession and leadership transition
January 6, 2026

Alvotech announces planned CEO succession and leadership transition

Indeterminate GlobeNewswire
Cartesian Therapeutics Announces New Employment Inducement Grants
January 6, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 6, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
NMD Pharma to present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

NMD Pharma to present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Kymera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
January 6, 2026

Kymera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13

Indeterminate GlobeNewswire
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
January 6, 2026

LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions